bertrand789
New member
Coronavirus : le pangolin retir? de la liste des ingr?dients de la m?decine traditionnelle chinoise
https://www.ladepeche.fr/2020/06/12/...se,8929269.php
https://www.ladepeche.fr/2020/06/12/...se,8929269.php
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Exclusive: Coronavirus began 'as an accident' in Chinese lab, says former MI6 boss
Sir Richard Dearlove tells Telegraph's Planet Normal podcast that new scientific report suggests key elements of the virus were 'inserted'
By Bill Gardner 3 June 2020 • 9:17pm
A former head of MI6 has said he believes the coronavirus pandemic "started as an accident" when the virus escaped from a laboratory in China.
In an interview with The Telegraph, Sir Richard Dearlove said he had seen an "important" new scientific report suggesting the virus did not emerge naturally but was man-made by Chinese scientists.
The apparent discovery will raise the prospect of China paying "reparations" for the death and economic catastrophe wreaked upon the world, the former intelligence chief said. It comes as Beijing faces growing pressure to explain precisely how coronavirus first began to spread late last year...
lin, X.; Chen, S. Major Concerns on the Identification of Bat Coronavirus Strain RaTG13 and Quality of Related Nature Paper. Preprints 2020, 2020060044 (doi: 10.20944/preprints202006.0044.v1).
Abstract
A recent manuscript (Zhou, P. et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin”, Nature 579, 270–273 (2020). https://doi.org/10.1038/s41586-020-2012-7) from Wuhan Institute of Virology claimed the identification of a bat coronavirus, RaTG13, which showed 96.2% genome homology with SARS-CoV-2. In this paper, we raise the puzzling observations surrounding the identification, characterization, unique genome features of this RaTG13 strain, as well as its 100% nucleotide identity in partial RdRp gene with another bat coronavirus strain BtCoV/4991. And the paper presented premature hypothesis of potential bat origin of SARS-CoV-2 while RaTG13 strain was not successfully isolated. We also present the concerns on the methodology, data quality and experiment procedures described in this paper. We call for the authors to provide additional data, to share related samples to be verified and further characterized by other scientists.
Subject Areas
Epidemiology; COVID-19; coronavirus; bat; RaTG13; BtCoV/4991; SARS-CoV-2; Pangolin Coronavirus; next generation sequencing
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Download PDF
Conclusion:
In summary, as a study that isolated first SARS-CoV-2 strain and identified a bat coronavirus
with high homology to SARS-CoV-2, it is critical that all data relating to viral genomes are of top
quality, since many studies used or might use them as reference sequences. Meanwhile,
although the leadership in Wuhan Institute of Virology might highlight their impressive speed to
complete all related experiments described in the paper16, the accurate patient sample
collection date and sequencing data with better quality needs to be recorded in the scientific
paper.
In addition, there have been no studies on RaTG13’s infectivity in bat/human cells or in animal
models, its interactions with antibodies or antiviral drugs. There is lack of understandings on
RaTG13’s virulence, transmissibility, pathogenicity, immune epitopes, immune evasion
mechanism, etc. This was because WIV did not isolate the RaTG13 virus and does not have any
related viral stocks, if the statement from Dr. Yanyi Wang (the director of WIV) in a recent TV
interview17 was accurate.
Therefore, a careful examination of the related RaTG13 samples and raw data sets of its
genome sequencing are warranted to exclude any possibilities of errors or the potential coinfection
of two different strains of coronavirus. And the authors need to clearly explain the
relationship between RaTG13 and BtCoV/4991, whether they were the same strain or two
closely related strains.
This paper was rushed to make a premature connection between bat coronavirus and SARSCoV-
2, drawing a potential bat origin scenario to support SARS-CoV-2 zoonotic transmission
from bat to human. However, this connection was based on a potential bat coronavirus strain
RaTG13, that may not truly exist, considering its key information missing: such as no related bat
sample description, no sequencing procedure details published, confusion/identity issue with
BtCoV/4991 strain, unusual sequence features, no viral isolation and related characterization,
et al.
In light of these concerns, we call for the retraction of this Nature paper1 to further verify the
sequencing data, patient sample collection date and provide more information regarding the
origin, identification and characterization of this BatCoV RaTG13. Proper verification should
involve Dr. Zhengli Shi sending the RaTG13 and BtCoV/4991-related bat samples to other noncollaborating
laboratories to be analyzed independently. And this Nature paper1 should be
cautious on making the “probable bat origin” hypothesis before RaTG13 existence could be
confirmed.
Did the SARS-CoV-2 virus arise from a bat coronavirus research program in a Chinese laboratory? Very possibly.
By Milton Leitenberg, June 4, 2020
Milton Leitenberg is a senior research associate at the Center for International and Security Studies at the University of Maryland (CISSM). His research is concentrated in three disparate areas of study: biological weapons; actual wars and conflicts of the past two decades and the issue of international intervention in these; and the history of nuclear weapons between the United States and Soviet Union and Russia between 1945 and 1995. CISSM published his major monograph, Biological Weapons Arms Control, in 1996. Since 1992, he has published over 30 papers in the area of biological weapons. Several of these papers concern the biowarfare program of the former Soviet Union, and The Soviet Biological Weapons Program: A History was published by Harvard University Press in 2013. Leitenberg published two other recent books on the subject of biological weapons: The Problem of Biological Weapons (National Defense College, Stockholm, 2004) and Assessing the Biological Weapons and Bioterrorism Threat (US Army War College, December 2005).
16:32, 02-Jul-2020
France says no link between origin of COVID-19, Wuhan lab
CGTN
France has recently announced that it does not have information to corroborate a possible link between the origin of the novel coronavirus and the Wuhan Institute of Virology...
Macron fury: France's 'strong ties' to Wuhan lab revealed amid coronavirus pandemic
EMMANUEL MACRON's France is one of many countries to be affected severely by the coronavirus pandemic - and one of the country's labs has strong ties with the Wuhan Institute of Virology which has been at the centre of false conspiracy theories.
By Charlie Bradley
PUBLISHED: 12:45, Thu, Jun 25, 2020 | UPDATED: 15:32, Thu, Jun 25, 2020
....The research centre is based in Lyon, France, and was a source of support for the developers of the Wuhan Institute of Virology.
A BSL-4 laboratory at the Wuhan Institute of Virology received significant and substantial support of the conceptual, engineering and logistical varieties from the International Center for Research in Infectious Diseases.
...
The Wuhan Institute of Virology's origin story has another link to France.
In 2004, the EU's chief Brexit negotiator Michel Barnier – then French Foreign Minister – signed a decree that led to the Wuhan lab's creation.
French firms got only minor roles in the building of the laboratory, and by the time it opened in 2017 cooperation had collapsed.
One group that has come under fire for its role in the pandemic is the Chinese Communist Party...
RaTG13 is a consensus sequence i.e. not draw from one infection in one bat but the most common sequences from pooled samples.